TAK-901
Code | Size | Price |
---|
TAR-T2709-5mg | 5mg | £124.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T2709-25mg | 25mg | £251.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T2709-50mg | 50mg | £385.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
TAK-901 has been used in trials studying the treatment of Lymphoma, Myelofibrosis, Multiple Myeloma, Myeloid Metaplasia, and Advanced Solid Tumors, among others.
CAS:
934541-31-8
Formula:
C28H32N4O3S
Molecular Weight:
504.65
Pathway:
Chromatin/Epigenetic; Cell Cycle/Checkpoint; Angiogenesis; Stem Cells; Tyrosine Kinase/Adaptors; JAK/STAT signaling
Purity:
0.9917
SMILES:
CCS(=O)(=O)c1cccc(c1)-c1cc(C(=O)NC2CCN(C)CC2)c(C)c2[nH]c3ncc(C)cc3c12
Target:
JAK; CDK; Src; Aurora Kinase
References
1. Pamela Farrell, et al, AACR, 2009, Abstract B270
2. Farrell P, et al. Mol Cancer Ther. 2013, 12(4), 460-470.